Neoadjuvant treatment combined with planned endoscopic surgery in locally advanced sphenoid sinus basaloid squamous cell carcinoma

Yinghong Zhang,Suqing Tian,Yali Du,Qiang Zuo,Li Zhu,Furong Ma

DOI: https://doi.org/10.1097/md9.0000000000000044

2022-01-01

Abstract:Introduction: Basaloid squamous cell carcinoma (BSCC) is a rare and aggressive variant of SCC. It often diagnosed at a late clinical stage and is associated with a poor survival rate, and the optimal sequence of treatment modalities remains unclear. Patient concerns: A 45-years-old male patient presented with 3 months history of left side nasal obstruction without rhinorrhea, olfaction loss, epistaxis, loss of visual acuity, and negative for family history of sinonasal carcinoma. Diagnosis: A transnasal biopsy was performed under general anesthesia. The Hematoxylin-eosin staining of the pathological slice and immunohistochemistry findings were consistent with the diagnosis of BSCC. Interventions: The patient was treated with planned endoscopic surgery after preoperative neoadjuvant cisplatin with concurrent radiation therapy. After neoadjuvant therapy, the tumor volume was reduced, facilitating transnasal radical resection. The endoscopic surgery was followed by radiation therapy. Outcome: Follow-up at 24 months post-surgery did not reveal any recurrence of the tumor. Conclusion: Neoadjuvant therapy consisting of radiation and cisplatin is a potentially effective therapeutic option in the treatment of locally advanced BSCC prior to surgical resection. This treatment and concurrent radiation followed by planned surgical resection results in significantly improved survival of the patients.